244460 — OliPass Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- KR₩7bn
- KR₩12bn
- KR₩756m
Annual income statement for OliPass, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,861 | 852 | 369 | 5,682 | 756 |
| Cost of Revenue | |||||
| Gross Profit | 1,855 | 476 | 369 | 5,127 | 277 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 27,324 | 25,995 | 22,294 | 19,196 | 10,952 |
| Operating Profit | -24,464 | -25,143 | -21,925 | -13,514 | -10,196 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -24,579 | -25,724 | -22,280 | -17,087 | -5,803 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -24,579 | -25,724 | -22,280 | -17,087 | -5,317 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -24,183 | -25,135 | -24,168 | -12,542 | -5,317 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -24,183 | -25,135 | -24,168 | -12,542 | -5,317 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -9,476 | -8,503 | -7,290 | -5,125 | -1,351 |
| Dividends per Share |